This document describes the radiotherapy方案 for colorectal cancer.
This is a chapter (pages 26–34) of the Portuguese handbook Guia Prático para o Oncologista Clínico covering treatment regimens for colorectal cancer. Each entry names a regimen, lists the drugs with their doses, route and days of administration, and gives the cycle interval and a numbered reference.
The chapter opens with radiotherapy combinations (5-fluorouracil plus radiotherapy and capecitabine plus radiotherapy) and continues with regimens such as 5-fluorouracil plus leucovorin, FOLFOX4, FLOX, FOLFIRI, XELOX, IROX, cetuximab and bevacizumab combinations. It ends with a numbered bibliography of journal references. Pages carry the footer 'Guia miolo correção_Manual Conflito.qxd 3/10/2011'. This manual is written in Portuguese.
Capecitabine 825 mg/m² orally twice daily during the entire radiotherapy, or 900–1,000 mg/m² orally twice daily on days 1–5 of each radiotherapy week.
1,000 mg/m²/day by continuous IV infusion on days 1 to 5, repeated in weeks 1 and 5 of radiotherapy.
Irinotecan 180 mg/m² IV on day 1, 5-fluorouracil 400 mg/m² IV bolus on day 1 followed by 2,400 mg/m² continuous infusion over 46 hours, and leucovorin 200 mg/m² IV on day 1, every 2 weeks.
XELOX (capecitabine 1,000 mg/m² orally twice daily on days 1–14 with oxaliplatin 130 mg/m² IV on day 1, every 21 days) and a capecitabine plus oxaliplatin regimen with bevacizumab.